Justin Renz
About Justin Renz
Justin Renz is the Chief Financial & Operations Officer at Ardelyx, with a rich background in finance and operations across several pharmaceutical companies.
Justin Renz - Chief Financial & Operations Officer
Justin Renz currently serves as the Chief Financial & Operations Officer. His role encompasses overseeing both financial operations and organizational efficiency, bringing a wealth of experience in corporate finance and strategic leadership.
Justin Renz's Educational Background
Justin Renz holds a Bachelor of Arts in Economics and Accounting from the College of the Holy Cross. He also earned a Master of Science in Taxation from Northeastern University, and a Master of Business Administration from Suffolk University. His diverse educational qualifications have equipped him with a strong foundation in both finance and business management.
Career Milestones of Justin Renz
Justin Renz has accumulated extensive experience in the pharmaceutical and financial sectors. He served as the president and chief financial officer of Correvio Pharma, where he led the sale of the company to ADVANZ PHARMA in May 2020. Prior to that, he was executive vice president, chief financial officer, and treasurer of Karyopharm Pharmaceuticals. At Zalicus Inc., he managed multiple rounds of equity and debt financings and facilitated a reverse merger and the sale of the company to EPIRUS Biopharmaceuticals Inc. in July 2014.
Justin Renz's Professional Experience
Justin Renz held various positions of increasing responsibility at EMD Serono Inc., ArQule, Inc., Coley Pharmaceutical Group, and Millipore Corporation. He began his career with Arthur Andersen LLP in 1993, which marked the start of a career characterized by strategic financial management and leadership across the biotech and pharmaceutical industries.